Medindia LOGIN REGISTER
Medindia

Arformoterol Tartrate Inhalation - Indications, Dosage, Side Effects and Precautions

Advertisement

Information about Arformoterol Tartrate Inhalation

Generic Name : Arformoterol Tartrate Inhalation
Up-to-date prescription details regarding Arformoterol Tartrate Inhalation are provided here.

Pronunciation : AR-for-MOE-ter-ol TAR-trate

Learn the correct pronunciation of the Arformoterol Tartrate Inhalation, understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, special precautions, warnings and its and its storage instructions.
You will also find a list of the medication's International and Indian brand or trade names, as well as its pricing information. For verification of the information presented on this page or for additional clarifications, it's advisable to consult your doctor.


ICD Code : Y55.6 Therapeutic Classification : Anti- Asthmatics

Trade Names/Brand Names of Arformoterol Tartrate Inhalation

International :


Brovana

Why is Arformoterol Tartrate Inhalation Prescribed? (Indications)

This medication is a long-acting beta-agonist bronchodilator, prescribed for chronic obstructive pulmonary disease (COPD).

When should Arformoterol Tartrate Inhalation not be taken? (Contraindications)

Contraindicated in patients with asthma, and hypersensitivity.

What is the dosage of Arformoterol Tartrate Inhalation?

Inhalation- The recommended dose is one 15-mcg unit-dose vial administered twice daily (morning and evening).

How should Arformoterol Tartrate Inhalation be taken?

It comes as a nebulizer for oral inhalation.

What are the warnings and precautions for Arformoterol Tartrate Inhalation?

• Caution should be exercised in patients with history of history of other breathing problems (eg, asthma), diabetes, heart or liver disease, high blood pressure, low blood potassium levels, seizures, overactive thyroid, irregular heartbeat, overexcitement, who are taking or have taken monoamine oxidase inhibitor (MAOI) within the last 14 days, any allergy, during pregnancy and breastfeeding.

• It may cause dizziness, do not drive a car or operate machinery while taking this medication.

• Monitor blood sugar, lung function and blood potassium levels regularly while taking this medication.

What are the side effects of Arformoterol Tartrate Inhalation?

Body as a Whole - Abscess, allergic reaction, digitalis intoxication, fever, hernia, injection site pain, neck rigidity, neoplasm, pelvic pain and retroperitoneal hemorrhage.
Heart - Blood clots in veins, abnormal heart rhythm, congestive heart failure, heart block, heart attack, prolonged QT interval and fast heart rate.
Gastrointestinal - Constipation, stomach inflammation, blood in stool, mouth infection, periodontal abscess and rectal bleeding.
Metabolic - Dehydration, fluid renetention, decreased glucose tolerance levels, gout, increase or decrease in blood glucose.
Musculoskeletal - Joint pain/inflammation, bone disorder, rheumatoid arthritis.
Central Nervous System - Agitation, stroke, decreased body movement, paralysis, drowsiness and tremor.
Respiratory - Lung cancer, respiratory disorder and voice alteration.
Skin - Dry skin, herpes simplex, herpes zoster, skin discoloration and skin hypertrophy.
Eye - Abnormal vision and glaucoma.
Genitourinary - Breast cancer, calcium crystalluria (presence of calcium phosphate crystals in urine sediment), blood in urine, kidney stone, night time urination, increase PSA levels, pus in urine, urinary tract disorder and urine abnormality.

What are the other precautions for Arformoterol Tartrate Inhalation?

Avoid excess dosage.

What are the storage conditions for Arformoterol Tartrate Inhalation?

Store the medication as directed by your physician.
Advertisement
Recommended Reading